Josh Krichefski Joins PMG as EMEA President
15.10.2025 13:00:00 CEST | Business Wire | Press Release
PMG, a global independent marketing services and technology company, today announced the appointment of Josh Krichefski to EMEA President, effective October 20th. In this new role, Krichefski will lead the strategy and expansion of PMG’s operations across the region, with a focus on scaling growth and driving excellence in customer delivery. He will oversee all aspects of the EMEA business, including commercial performance, talent development, and the introduction of new capabilities and partnerships aligned to PMG’s global vision. Krichefskiwill be based in PMG’s London office and will partner directly with George Popstefanov, Founder & CEO and Jon Dupuis, Global President.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015978859/en/
Josh Krichefski
Dupuis commented: “Josh’s appointment marks an exciting next chapter in our EMEA growth. With more than two decades of experience in shaping agencies and teams across Europe, Josh brings a deep understanding of both the region holistically and the strategic importance of individual markets. Josh’s leadership style reflects PMG’s values—curiosity, agility, and a relentless focus on transformation. His track record speaks for itself, but it’s his alignment with our people-centric culture and customer-obsessed mindset that makes this such a strong fit. We will partner closely to build on the strong momentum we already have in EMEA, continuing to deliver exceptional outcomes for our customers across the region.”
Krichefski, having most recently served as CEO of GroupM EMEA where he led 17,000 people and oversaw $22 billion in media investment billings across 42 markets, brings three decades of experience in agency leadership and brand transformation across a number of firms, including as Global Chief Operating Officer of EssenceMediacom and CEO of MediaCom in the UK and EMEA.
Krichefski said: "I'm incredibly excited to be joining PMG at such a pivotal moment in its growth journey. What drew me to the business goes beyond its impressive trajectory. PMG sits at the intersection of talent, technology and transformation—built for a marketing landscape that demands agility, speed, and innovation. From the outset, I saw a values-driven business that aligns with my own, putting people and customers at the center, while leaning into a future powered by AI, transparency, real-time decisioning, and connected platforms. It’s that combination of purpose, modernity, and momentum that makes this opportunity so energizing.”
Krichefski’s arrival coincides with significant global expansion for PMG, marked by a 20% year-on-year growth. It also follows a series of high-profile leadership appointments in recent months including: Leah Meranus to SVP Customer Success, Matt Dailey as Head of Analytics & Measurement, EMEA, Chad Stoller as Global Head of Media, and Andrea Terrassa as Chief Operating Officer. These additions reflect PMG’s commitment to shaping the future of marketing and advertising through technology, expertise, innovation, and operational excellence.
PMG’s acquisition of Camelot Strategic Marketing & Media, followed by UK-based RocketMill, and more recently, Momentum Commerce, further expanded its global footprint and retail media capabilities.
As part of its ongoing commitment to advancing the technology and AI foundation of the marketing industry, PMG unveiled Alli Marketplace at this year’s Cannes Lions. This first-of-its-kind media-buying solution is fully integrated into its proprietary Alli operating system. The launch featured 22 initial platform and publisher partners and offers marketers unprecedented control, transparency, and speed through automated, intelligence-driven media investments.
About PMG
PMG is a global independent marketing services and technology company that seeks to unlock potential for people and brands. Driven by shared success, PMG brings together business strategy and transformation, creative, media, and insights, all powered by our proprietary marketing operating system, Alli. With offices in New York, London, Dallas & Fort Worth, Austin, Atlanta, Brighton, Costa Rica, Cleveland, and Dusseldorf, our team is made up of more than 1,000 employees globally, and our work for brands like Apple, CKE Restaurants, Dropbox, Experian, Intuit, Kohler, Sephora, Travelex, and Whole Foods has received top industry recognitions including Cannes Lions and Adweek Media Plan of the Year.
Named The Drum’s 2024 Agency of the Year, Digiday’s 2024 Independent Media Agency of the Year, Ad Age’s 2023 A-List, MediaPost’s 2022 Independent Agency of the Year, and Adweek’s 2021 Breakthrough Media Agency, PMG has grown through commitments to continuous improvement, business integrity, and cultivating dynamic relationships. PMG is proud to be named among Fast Company’s Best Workplaces for Innovators, Best Workplaces for Women, and to be the only company named to Ad Age’s Best Places to Work for 10 years in a row. For more information about PMG, visit www.pmg.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251015978859/en/
Contacts
Media Contact:
Rose Marie Adamo
Global Head of Marketing and Communications
+1 954.260.9358
rosemarie.adamo@pmg.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom